Favorable survival observed after carboplatin, paclitaxel, and concurrent accelerated hyperfractionated radiotherapy for treatment of locally advanced head and neck carcinoma.

Source:http://linkedlifedata.com/resource/pubmed/id/18473121

Download in:

View as

General Info

PMID
18473121